Hyundai Bio plans trials of antiviral for dengue fever

South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral

Dr. B: Expanding the business model from COVID vaccines to a...

Cyrus Massoumi, founder of Dr.

EU sets aside €45m for coronavirus drug and diagnostic R&D

US trials of Gilead's remdesivir begin against COVID-19 coro...

The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.

COVID-19 could disrupt supplies of cheap generics, analysts ...

An extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on to keep costs as low as possible, according to a new report from ratings